ASX - General. 0. It is lengthy but well worth the time. my apologies that I could not stay after the. Market . distraction achieved. Good luck to all. Hey, "smart", I concur with your message. Still waiting for you @antibotter to explain why it appears you tried to influence newbies and less experienced investors into thinking that something big was imminent based on a comment in the SPL newsletter. 0 Created with. 8. com Investors: Chas Cook — 336-436-5076 Investor@Labcorp. 0. HotCopper is Australia's largest free and independent stock market trading forum for. Join the HotCopper ASX share market forum today for free. It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased. I averaged down over the next year and the lowest point I bought was at 57c. Share lol @col69 the phrase "in parallel we are continuing discussions with potential commercial partners" is now etched into SPL's manual for any asx announcements or releases to the public. . ASX - By Stock. Furthermore the shameful and disappointing thing is that some pumpers on this forum were encouraging newbies (even when the SP hit its $2. Application for quotation of securities - SPL. Application for quotation of securities - SPL. Click for more information. Last updated 15. ASX - By Stock. They need IMO to define good and any other qualifying words !!. Starpharma AGM Summary (Part 1) Oh. Today it closes up 5% on the high of the bar and all we here. 9¢. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. it's a mess with multiple Substantial Holders dumping like this all while HQ remain. Cristal therapeutics. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. ASX - General. Starpharma have so far been quite disappointing in the way it has commercialised products The Vivagel condom A dismal failure so far It had been approved. SPL Price at posting: $1. 48. Last updated 15. I've been a SPL shareholder since Nov 2015 when I bought a small parcel at 91c. A halleluljah announcement just days before the AGM would imo be proof that investors in SPL have for years been treated like mugs. . Maybe some positive news coming out of Starpharma CEO's busines trip to America over coming daysFor shareholder it is a task of getting a CEO who can make hard decisions based on what does happen but with shrinking internal candidates progress it triggered red flags for me a sif you were very confident and could show progress and efficacy new candidated would and could be funded / partnered so IMO odd to close down or delay. Join the HotCopper ASX share market forum today for free. 5¢. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 59pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on SYRAH RESOURCES LIMITED. Charts. m. ASX - Day Trading. ASX - By Stock. Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. 0. Remember that according to AZ’s own data, no patient had yet met the formal criteria of a response. also not sure why anyone should get excited about a daily decrease in the short position of 0. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 409118. 0%. 70. ASX - Day TradingSPL buy back distribution agreement , LLoyds hand it back or SPL formally takes action for the agreement to be cancelled due to a default in obligations. . yet if one considers that the amount of millions of shares via option they. Created with Sketch. ASX - Day Trading. Add SPL (ASX) to my watchlist (20min delay). SPL's current SP is about 15 cents, after many years (some say 20 years) of unprofitability, during which time substantial salaries and performance bonuses appear to have been paid. 8¢. Created with Sketch. Despite the length of time that SPL has been in existence, it is obvious that some players think that SPL is currently overvalued, hence the relentless selling. 26. , page-2. 3¢. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. . Join the HotCopper ASX share market forum today for free. 5. Charts. ASX - Day TradingShare Can you point out what you believe are their failings with respect to regulatory filings for a "medical device"? Also do you consider that government and regulatory sentiment may have had an impact on consumer demand and any advertising plan - its clear that Governments are still fixated on Vaccination to the disregard of any. $-0. SPL Price at posting: 91. 0. Or primary care stop like a medical centre or clinic- stating the obvious- hope SPL have better marketers than I) Also would like to see what the USA have done to allow retail investor to get involved in per IPO rather than just institutions investors getting the huge discount to Share Price. . Advertise on HotCopper. Market . Charts. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. And that is my opinion too but about SPL. Join the HotCopper ASX share market forum today for free. Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). 0¢. 375) mark and followed up with a roughly 23. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. 1029/9/2000 SPL $0. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. I remember seeing a post on SPL had 41000 views. Market . The thread is titled so that it can be found and general enough so as to. However, I think that maybe SPL is occasionally worth a swing trade gamble. ASX - By Stock. News: SPL Starpharma Holdings Appoints Cheryl Maley As CEO & Managing Director: 10/11/23 : 0: 94: 10/11/23: Last post Hot News: Created with Sketch. 0012. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer. 5¢. Latest Posts. It totally unrealistic that Merck will enter the clinic in 4-5 months. Market Cap $77. If only we had the viraleze. 00 and $5. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Actually I worked for a research firm that supplied SPL with online medical literature and patent research back in the early 2000s. m. " Indeed. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Timeline. Last updated 15. Commodities. 0834. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Created with Sketch. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. To me, that totally. 63. 25. , page-3. And somebody must be buying all the shares that are being sold. Created with Sketch. Created with Sketch. While the chart is not good there is a glimmer hope maybe emerging. 43M. $0. great news but unlikely. One of those is worse that SPL. Forums. Maybe SPL is frustrated at the lack of promotion, or maybe they have frustrated McKesson with continuity of supply, but I doubt it this early in the relationship - the logistics will be guided by demand, and it takes time to find the right equilibrium without overcommitting funds and/or scaling up manufacturing capacity, honouring contracts etc. Forums. Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. Created with Sketch. . I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. Latest Posts. This of course is on the back of long-serving lap dog and CFO/Secretary Nigel Baade resigning around the same time that the ASX asked Starpharma questions regarding continuous disclosure obligations and also whether a SPL announcement was tantamount to ramping. 76. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Latest Posts. Last updated 14. Created with Sketch. 36. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. But the products were developed as proof of a saleable dendrimer product. Target our investor community with our suite of Hotcopper. I should declare that I am. 56. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. Just begin to imagine that all staff on board use Viraleze well before. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions. Forums. . With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. . I look forward to holding SPL at task - this will be the third time I have been involved in pushing for a shareholder class action, which I can say on the previous two occasions resulted in a more communicative and transparent company, which ultimately is what I. Target our investor community with our. Advertise on HotCopper. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Become a member of Australia's largest investment discussion forum. 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. . . Twelve month SPL daily chartSame old trend continues. 58pm 20/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. The real story is SPL hasn't been 63 cents since 24/3/2020 that's not a 52-week low, that's a 114-week low! 2 years 3 months since its seen that price. 0. Extract taken from recent interview with CEO of Starpharma Does it surprise you that big pharma hasn't come in and swooped in and bought the business to. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. 607432. New Zealand Dollar. . If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc . Join the HotCopper ASX share market forum today for free. . Ena Respiratory is getting news coverage everywhere - newspapers, onilne, 7 morning news, more coverage than I've seen for SPL - “By boosting the natural immune response of the ferrets with our treatment, we’ve seen a rapid eradication of the virus,” he explained in a statement. 00%. Unusual to make that announcement?. An expat Indonesian friend did have search for me but didn't find any promotion etc a little while ago. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’: SPL are obliged to make announcements and unfortunately they have not included enough detail so shareholders are aware of timings and actual release in Indonesia nor real scale. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. . Created with Sketch. The rules obviously do not apply in Starpharma Land with CEO Jackie Fairley. . 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. So the Scripps evidence of efficacy will be the main basis for the decision. Taking Cols scenario for a sting like buyout if the buyout price is higher than the highest price the company has reached there is no avenue for complaint. . Forums. 50 or. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 0¢. . Canadian Dollar. It looks like SPL will need a BLOCKBUSTER ANNOUNCEMENT with $$$$$ attached plus a SATURN ROCKET up its clacker to take off. HotCopper has news,. ASX - By Stock. Created with Sketch. A correctly formatted example follows: Title of my presentation for the conference. $0. I am not up to date with all brexit stuff let alone othe rcountries like Vietnam , HK and very cautiious about consultants websites and simply govt websites area nightmare to understand and navigate unless it is your speciality. Surely the political restraints. International Markets. ASX - Day TradingLet's face it SPL is a very small investment for most of the institutions, they work on the basis of having a portfolio of these "penny dreadfuls" and expect some to come good but most to fail. Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. LEADING THE BATTERY METALS REVOLUTION. Last updated 15. . My portfolio has risen 95% since I sold SPL with conviction. ASX - Short Term Trading. Don’t look to him for the truth lol. caBC OnLine Partnership Office E161, 4000 Seymour Place PO Box 9412, Stn Prov Govt Victoria, BC V8W 9V1Share. Provide some keywords to assist in categorisation of your abstract. I think SPL are very worried on what a potential class action could implicate. 5¢. 75802. All that seems to happen is that new verses are sometimes added. Market . $-0. Is this a case of short memories? The best one can say is her surprise is disingenuous. Join the HotCopper ASX share. LEADING THE BATTERY METALS REVOLUTION. 17112. Let's not forget that this happened due to the poor performance of management that contributed to SPL getting the boot from. Market . SPL Price at posting. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. 63. rights. 57. 12. ACCELERATE RESOURCES LIMITED. ASX - By Stock. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. You got to wonder after huge volumes going through last 4 days and the SP reaching new lows. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . It seems long-suffering retail. ASX - By Stock. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. m. 49M. 03% or subsequently a decrease in shorts of. The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. Target our investor community with our suite of Hotcopper Advertising opportunities. . The Vancouver Island Wave program is the Island’s highest level of youth soccer participating in the BC Soccer Premier League. . Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 70 Sentiment: Sell Disclosure: Held Not only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and dose escalation apparently continues. I am closely watching the state of the World Economy, particularly China and the U. 2:00 am Eastern Standard Time Australia. 00%. Additionally, three of the companies mentioned that have approved and marketed IO. . 1 Introduction. This is just a lifestyle company at this point, management just keeping the company afloat with announcements that have no tangible impact on the share price while they collect their salaries. Notification of cessation of securities - SPL. 5 years Starpharma has not publicly released any information to the ASX about progress of the partnership. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. 0. Phillip Altman is a highly-respected and well-known Australian authority on clinical trials and drug regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration (TGA) in gaining new drug approvals. Energy. 11%. Build your trading strategy and connect with. m. Sorry a Faulty Towers and BMC tragic and possibly a SPL one as well . Application for quotation of securities - SPL. My theory is we had a large accumulator that was content buying. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. The AGM has come and gone What did we learn from this meeting according to our attendee's who post on HotCopper forum When it comes to. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. Our magic little formula may just be the answer. I just hope that Starpharma shareholders sit up and notice at how the leaders of our company (the Chairman and CEO). 3. 9¢. They not even have a license with SPL, just a basic research agreement. They are the future as also mentioned regularly by Eric Topol. 0¢. 8985. Their IP doesn't last forever - you need to hustle in pharma. Created with Sketch. SPL could announce tomorrow that DEP doesn’t work and they’ll still find a way to spin it positively. 82%)And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - By Stock. However, the interim results from ongoing Phase One NCT04865419 (the most advanced trial) was a little underwhelming IMO. 11%. 37pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on WHISPIR LIMITED. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. However, just a word of caution before the usual pumping starts by the usual suspects. Market Dep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. 36pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on SPARC TECHNOLOGIES LIMITED. Is the board simply resting on their collective (pre spl) laurels?Just in case you missed it HEALTHCARE Starpharma (SPL) Strong results from first in man Phase 1 DEP Docetaxel trial validate SPL’s DEP platform Safety. ROFL. ASX - Day Trading. SPL polylycine dendrimers are proving to play a major role in the future of ADC’s. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’:Peak of the UK Flu season looks to have passed . My understanding is this condition has not been met however each KMP has received 191,152 rights for this alongside other staff whose allocation will no doubt vary according to the capacity of their employment. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. 70% 14. 3¢. Time flies. Created with Sketch. I will be unable to listen to the AGM but look forward to listening to the audio and reading Hotcopper comments and feed back after my afternoon shift. Merck -- 2. 75. Dr. $0. 5¢. 06 Sentiment: Buy Disclosure: Held Created with Sketch. Created with Sketch. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Change in substantial holding. Hope that SPL starts to deliver on its promises. DJPIN. Latest Posts. Charts. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Disowned him really. Created with Sketch. Viraleze being 1% less efficacious against the more potent dangerous new strains is an awesome result and should be celebrated. The results will be good but will they be good enough for SPL to be able to do the deals. 0¢. Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. Created with Sketch. AX8. Starpharma was 96 cents in April 2002. Join the HotCopper ASX share market forum today for free. So far no one wants to add anything except to get. 1dB. SPL Price at posting: 16. SPL have put a lot of time and energy into Docetaxel and Cabazitaxel over many years but it is Irinotecan that seems to be wining the race, probably benefiting from the accrued knowledge from the Doc and Cab trials. It must be great to ride the ASX executive remuneration gravy train like CEO Fairley has done for 18 years with Starpharma, and Chairman Rob Thomas has done for the majority of his long career. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. ASX - Day TradingMelbourne, Australia; 6 May 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ antiviral nasal spray is now available for purchase by consumers in Europe via Starpharma’s webstore. Last updated 15. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no. 24am 31/10/2023 ? Share Prices & Charts for STARPHARMA HOLDINGS LIMITED. $1. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. . Interesting write-up. 7¢. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 50 At this stage in the game, I would not accept anything under $5 (fact)Btw if Starpharma do receive an upfront milestone of $300 million for Dep Docetaxel, Dep Cabazitaxel and Dep Irinotecan license, I believe a special dividend will be paid out to all. 8¢. Some links within this article worth a scan too. SPL is tanking, HQ are overpromising and under delivering. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. ASX - By Stock Forum | Join the HotCopper forum today for free. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. Latest Posts. DISCOVER THE BATTERY METALS. A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. But I’ve been having a. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 70. Hey, "smart", I concur with your message. * All the touted pending/expected deals with the Majors come to very little with the usual statement "in discussions"Created with Sketch. Views. 3¢ STARPHARMA HOLDINGS LIMITED - Discussion. SPL. Jackie in the discussion talked about dealing with the tourist industry. Both were very well paid and, if the "forward looking statements" are to be believed would have had the box seat in a company with a great future. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial upfront payment then a CR will definately be on the cards. More. I can't guess where or what or when, perhaps there is an informed opinion out there in HC SPL land but we have a very tight market and some. Share Yes, this is pre-clinical data, HOWEVER, on this occasion this positive data (of adding Starpharma’s conjugate to IO drugs) directly supports commercial negotiations for the soon to be released top-line results for DEP-Irinotecan, in my opinion. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. . 45K. Enter the title of your abstract. 0 Great. I have today made my own enquiries with AstraZeneca directly on 1-877-240-9479 and they (Camellia) have confirmed that this trial is not yet recruiting and she also confirmed that the day recruitment starts the status on the website will be updated. Latest Posts.